Latest Breaking News On - Optum clinformatics data mart - Page 1 : comparemela.com

Second-Line Venetoclax Associated With Real-World Cost Savings vs BTK Inhibitors in CLL/SLL

Second-Line Venetoclax Associated With Real-World Cost Savings vs BTK Inhibitors in CLL/SLL
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesStanford universityBita fakhriOptum research databaseStanford university schoolOptum clinformatics data mart

Specialty Care Access Not Equal Among Teens With Diabetes

Claims for specialists significantly lower for youth with type 2 versus type 1 diabetes

New yorkUnited statesMedpage todayOptum clinformatics data martNew york city

Biosimilar Biologics Do Not Always Reduce Out-of-Pocket Costs

Findings seen in large study of commercially insured outpatients examining 7 biologics, before and after biosimilar availability.

United statesKimberly fengHealth forumHealthday newsOptum clinformatics data mart

Similar health costs after gastric bypass, sleeve gastrectomy for adults with diabetes

Similar health costs after gastric bypass, sleeve gastrectomy for adults with diabetes
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Stephanie argetsingerBymichael monostraKristinah lewisRichard smithHarvard medical schoolHarvard pilgrim health care instituteWake forest university school of medicineWake forest university schoolOptum clinformatics data mart

Biosimilar biologics do not always reduce out-of-pocket costs

Biosimilar biologics do not always reduce out-of-pocket costs
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesAndreww mulcahyKimberly fengHealth forumOptum clinformatics data martPatient out of pocket costsBiologic drugs after biosimilar competitionRevisiting expectationsOne piece